Table 2.
Summary RRs (95% CIs) of pancreatic cancer with leisure-time, moderate and vigorous physical activity in all prospective studies and in subgroups according to study characteristics
| N studies/ n estimates |
RR (95% CI) | P Heterogeneity | P Interaction | |
|---|---|---|---|---|
| Leisure-time physical activity | ||||
| All prospective studies | 14/17 | 0.94 (0.84, 1.05) | 0.6 | |
| Region | ||||
| North America | 6/6 | 1.06 (0.88, 1.28) | 0.39 | |
| Europe | 5/6 | 0.84 (0.70, 1.02) | 0.78 | 0.08 |
| Asia | 3/5 | 0.88 (0.69, 1.13) | 0.58 | 0.23 |
| Sex* | ||||
| Men | 9/9 | 0.92 (0.78, 1.09) | 0.96 | 0.79 |
| Women | 8/8 | 0.90 (0.70, 1.16) | 0.22 | |
| Follow-up | ||||
| <10 years | 4/4 | 0.90 (0.74, 1.11) | 0.38 | 0.71 |
| ≥10 years | 10/13 | 0.95 (0.83, 1.09) | 0.55 | |
| Adjustment for BMI or diabetes | ||||
| Yes | 11/13 | 0.93 (0.81, 1.06) | 0.88 | 0.84 |
| No | 3/4 | 0.88 (0.59, 1.29) | 0.07 | |
| Moderate physical activity | ||||
| All prospective studies | 6/7 | 0.83 (0.58, 1.18) | <0.001 | |
| Region | ||||
| North America | 5/5 | 0.76 (0.47, 1.24) | 0.001 | 0.62 |
| Multiethnic | 1/2 | 0.95 (0.50, 1.82) | 0.014 | |
| Sex* | ||||
| Men | 2/2 | 0.75 (0.24, 2.36) | 0.001 | 0.89 |
| Women | 4/4 | 0.75 (0.51, 1.09) | 0.09 | |
| Follow-up | ||||
| <10 years | 1/2 | 0.95 (0.50, 1.82) | 0.014 | 0.62 |
| ≥10 years | 5/5 | 0.76 (0.47, 1.24) | 0.001 | |
| Adjustment for BMI or diabetes | ||||
| Yes | 5/6 | 0.77 (0.50, 1.17) | <0.001 | 0.46 |
| No | 1/1 | 1.14 (0.79, 1.65) | NA | |
| Vigorous physical activity | ||||
| All prospective studies | 7/7 | 0.94 (0.80, 1.12) | 0.717 | |
| Region | ||||
| North America | 6/6 | 0.89 (0.73, 1.07) | 0.899 | 0.15 |
| Europe | 1/1 | 1.21 (0.83, 1.77) | NA | |
| Sex* | ||||
| Men | 2/2 | 1.04 (0.68, 1.60) | 0.247 | 0.20 |
| Women | 4/4 | 0.79 (0.59,1.06) | 0.46 | |
| Follow-up | ||||
| <10 years | 2/2 | 1.06 0.82, 1.35) | 0.346 | 0.23 |
| ≥10 years | 5/5 | 0.86 (0.68, 1.08) | 0.848 | |
| Adjustment for BMI or diabetes | ||||
| Yes | 6/6 | 0.95 (0.79, 1.13) | 0.594 | 0.96 |
| No | 1/1 | 0.93 (0.55, 1.57) | NA |
Included only studies that reported sex-specific estimates.